CA9 and nonpapillary renal cell carcinoma: In our study, the gene expression of CA9 was significantly increased (>2-fold) in 100% of ccRCC patients (21/21; Figure 3D) including four initial selected ccRCC, sixteen additional ccRCC (Figure 2B) and one case (Figure 3A and B) used in comparing experiment.